caffeine has been researched along with Chronic Hepatitis C in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The inclusion criterion was observational studies' assessment of the impact of caffeine consumption in adult patients with chronic hepatitis C." | 8.95 | Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis. ( Jaruvongvanich, V; Klomjit, N; Sanguankeo, A; Upala, S, 2017) |
| "The purpose of this study was to evaluate caffeine clearance, a quantitative measurement of metabolizing capacity of the liver, in chronic hepatitis B and C before and after interferon treatment." | 5.09 | Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy. ( Mahachai, V; Wittayalertpanya, S, 2001) |
| " The inclusion criterion was observational studies' assessment of the impact of caffeine consumption in adult patients with chronic hepatitis C." | 4.95 | Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis. ( Jaruvongvanich, V; Klomjit, N; Sanguankeo, A; Upala, S, 2017) |
| "Coffee or caffeine has been proposed to protect against hepatic fibrosis, but few data are available on their effects in patients with chronic hepatitis C virus (HCV) infection." | 3.81 | Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. ( El-Serag, HB; Kanwal, F; Khalaf, N; Kuzniarek, J; Mittal, S; Ramsey, D; Tavakoli-Tabasi, S; White, D, 2015) |
| "Obesity, non-alcoholic fatty liver and steatohepatitis as well as diabetes mellitus together also form a significant risk for HCC, due to the gradually increasing number of patients." | 2.46 | [Role of environmental factors in the etiology of hepatocellular carcinoma]. ( Tornai, I, 2010) |
| "Caffeine intake was compared between patients with mild and advanced liver fibrosis (bridging fibrosis/cirrhosis)." | 1.36 | Increased caffeine consumption is associated with reduced hepatic fibrosis. ( Everhart, JE; Feld, JJ; Hoofnagle, JH; Kleiner, DE; Liang, TJ; Modi, AA; Park, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaki, Y | 1 |
| Ohfuji, S | 1 |
| Fukushima, W | 1 |
| Tamori, A | 1 |
| Enomoto, M | 1 |
| Habu, D | 1 |
| Iwai, S | 1 |
| Uchida-Kobayashi, S | 1 |
| Fujii, H | 1 |
| Shiomi, S | 1 |
| Kawada, N | 1 |
| Hirota, Y | 1 |
| Khalaf, N | 1 |
| White, D | 1 |
| Kanwal, F | 1 |
| Ramsey, D | 1 |
| Mittal, S | 1 |
| Tavakoli-Tabasi, S | 1 |
| Kuzniarek, J | 1 |
| El-Serag, HB | 1 |
| Jaruvongvanich, V | 1 |
| Sanguankeo, A | 1 |
| Klomjit, N | 1 |
| Upala, S | 1 |
| Purnak, T | 1 |
| Ozaslan, E | 1 |
| Modi, AA | 1 |
| Feld, JJ | 1 |
| Park, Y | 1 |
| Kleiner, DE | 1 |
| Everhart, JE | 1 |
| Liang, TJ | 1 |
| Hoofnagle, JH | 1 |
| Tornai, I | 1 |
| Costentin, CE | 1 |
| Roudot-Thoraval, F | 1 |
| Zafrani, ES | 1 |
| Medkour, F | 1 |
| Pawlotsky, JM | 1 |
| Mallat, A | 1 |
| Hézode, C | 1 |
| Cardin, R | 1 |
| Piciocchi, M | 1 |
| Martines, D | 1 |
| Scribano, L | 1 |
| Petracco, M | 1 |
| Farinati, F | 1 |
| Wittayalertpanya, S | 1 |
| Mahachai, V | 1 |
2 reviews available for caffeine and Chronic Hepatitis C
| Article | Year |
|---|---|
Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.
Topics: Administration, Oral; Beverages; Caffeine; Central Nervous System Stimulants; Hepatitis C, Chronic; | 2017 |
[Role of environmental factors in the etiology of hepatocellular carcinoma].
Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Caffeine; Carcinoma, Hepatocellular; Coffee; Contracepti | 2010 |
3 trials available for caffeine and Chronic Hepatitis C
| Article | Year |
|---|---|
Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.
Topics: Aged; Alanine Transaminase; Caffeine; Central Nervous System Stimulants; Energy Drinks; Female; Foll | 2013 |
Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Alanine Transaminase; Aspartate Aminotransferases; Caffeine; Coff | 2013 |
Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy.
Topics: Administration, Oral; Adult; Caffeine; Chromatography, High Pressure Liquid; Female; Hepatitis B, Ch | 2001 |
4 other studies available for caffeine and Chronic Hepatitis C
| Article | Year |
|---|---|
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
Topics: Adult; Aged; Caffeine; Coffee; Cross-Sectional Studies; Feeding Behavior; Female; Hepatitis C, Chron | 2015 |
Coffee intake and chronic hepatitis C.
Topics: Antiviral Agents; Caffeine; Coffee; Cytochrome P-450 CYP1A2; Disease Progression; Drinking Behavior; | 2009 |
Increased caffeine consumption is associated with reduced hepatic fibrosis.
Topics: Adolescent; Adult; Aged; Caffeine; Coffee; Diet Surveys; Female; Hepatitis C, Chronic; Humans; Liver | 2010 |
Association of caffeine intake and histological features of chronic hepatitis C.
Topics: Adult; Caffeine; Coffee; Female; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Multivariat | 2011 |